Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06488001 · ClinicalTrials.gov registry record · Phase 2
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
A Phase 2 study of Postoperative Nausea and Vomiting, sponsored by United States Naval Medical Center, Portsmouth.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT06488001 is a Phase 2 study of Postoperative Nausea and Vomiting that is actively recruiting participants, run by United States Naval Medical Center, Portsmouth. The registered enrollment target is 132 participants, below the 456-participant average among 9 other Postoperative Nausea and Vomiting trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06488001, a Phase 2 study of Postoperative Nausea and Vomiting, is actively recruiting participants, sponsored by United States Naval Medical Center, Portsmouth.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to see if pantoprazole (a proton pump inhibitor used for acid reflux/heart burn) can reduce nausea and vomiting after gynecologic surgery in women between the ages of 18 and 79. Researchers will compare a placebo to the active medication. Participants will be asked to take three pills around their surgery, two taken before and one taken the night after.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG pantoprazole
Study Locations (1)
Virginia
- Naval Medical Center Portsmouth - Portsmouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2022-08-26 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06488001
The ClinicalTrials.gov registry entry for NCT06488001 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 456-participant average among 9 other Postoperative Nausea and Vomiting trials with a reported enrollment target (71% lower). The listed sponsor is United States Naval Medical Center, Portsmouth, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Nausea and Vomiting appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06488001 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06488001 about?
NCT06488001 is a clinical study titled "Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery". The goal of this clinical trial is to see if pantoprazole (a proton pump inhibitor used for acid reflux/heart burn) can reduce nausea and vomiting after gynecologic surgery in women between the ages of 18 and 79. Researchers will compare a placebo to the active medication. Participants will be ask...
What is the current status of trial NCT06488001?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 132 participants. The study started on 2022-08-26. Estimated completion is 2026-12.
What conditions does trial NCT06488001 study?
This clinical trial studies the following conditions: Postoperative Nausea and Vomiting.
What interventions are being tested in trial NCT06488001?
The interventions under investigation include: Placebo (DRUG), pantoprazole (DRUG).
Who is sponsoring clinical trial NCT06488001?
This trial is sponsored by United States Naval Medical Center, Portsmouth, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06488001 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Nausea and Vomiting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)
COMPLETED · Phase 2
-
Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.
RECRUITING · NA
-
Costs of Postoperative Nausea and Vomiting in Ambulatory Surgery Patients
COMPLETED
-
Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children
COMPLETED
-
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
COMPLETED · Phase 3
-
Study of APD421 as PONV Treatment (Prior Prophylaxis)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.